OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
18
Results
Show all
Save search
Copy query
Show results for
Unknown
(18)
Publication Date
Release Date
2022
(2)
2021
(2)
2016
(2)
2015
(2)
2014
(2)
2025
(1)
2024
(1)
2023
(1)
2020
(1)
2017
(1)
2012
(1)
2010
(1)
2008
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Consistent Performance of GPT-4o in Rare Disease Diagnosis Across Nine Languages and 4967 Cases.
Not available
S-EPMC11888497
|
biostudies-literature
Cite
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
Not available
S-EPMC7787219
|
biostudies-literature
Cite
Target ranges of oxygen saturation in extremely preterm infants.
Not available
S-EPMC2891970
|
biostudies-literature
Cite
Patterns of Oxygenation, Mortality, and Growth Status in the Surfactant Positive Pressure and Oxygen Trial Cohort.
Not available
S-EPMC5484739
|
biostudies-literature
Cite
Growth Outcomes of Preterm Infants Exposed to Different Oxygen Saturation Target Ranges from Birth.
Not available
S-EPMC5327617
|
biostudies-literature
Cite
PaCO2 in surfactant, positive pressure, and oxygenation randomised trial (SUPPORT).
Not available
S-EPMC4336211
|
biostudies-literature
Cite
Neurodevelopmental outcomes in the early CPAP and pulse oximetry trial.
Not available
S-EPMC4140695
|
biostudies-literature
Cite
Growth Rates of Infants Randomized to Continuous Positive Airway Pressure or Intubation After Extremely Preterm Birth.
Not available
S-EPMC8478787
|
biostudies-literature
Cite
Respiratory outcomes of the surfactant positive pressure and oximetry randomized trial (SUPPORT).
Not available
S-EPMC4111960
|
biostudies-literature
Cite
Evaluating retinopathy of prematurity screening guidelines for 24- to 27-week gestational age infants.
Not available
S-EPMC3969774
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets